Clinical trials in the news

But what can a person do if their dog is given a devastating diagnosis of cancer? April 3, — Investigational vaccine designed to provide broad, durable protection from flu. Jahleel was diagnosed with GATA2 deficiency, a rare genetic disease that causes a wide range of symptoms, including myeloid leukemias.

February 11, — Natural News reported a study led by Dr. January 30, — Scientists funded by the National Institutes of Health have developed a new assay to accurately and easily count the cells that comprise the HIV reservoir, the stubborn obstacle to an HIV cure.

January 14, — Clostridium difficile, commonly referred to as C. September 20, — Clinical trial will evaluate whether treatment is safe for people living with HIV. June 4, — A novel approach to immunotherapy developed by researchers at the National Cancer Institute NCI has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments.

June 4, — Results could play a role in bringing targeted treatments to patients with certain gene abnormalities, regardless of their cancer type. January 24, — Clinical trial will compare three antiretroviral drug regimens. December 11, — Combination allows more than 80 percent of children to safely consume at least two foods to which they were allergic.

November 28, — A recent NIAAA study has shown that people who drink socially and have certain risk factors for alcohol use disorder AUD self-administer more alcohol and at a faster rate during a single session of alcohol consumption in a laboratory setting than people at low risk for developing AUD. November 13, — The new high blood pressure guidelines illustrate the utility and impact of NHLBI scientific studies. October 17, — Two test vaccines for Ebola were safe and induced lasting immune responses in a study with 1, adults in Liberia.

The findings are an important step in development of a vaccine. September 19, — They ranged in age from 15 to 61—four African American women, all with stories to tell about their struggles with sickle cell disease, all with stories about a common experience that helped them through those struggles: participating in clinical trials. July 24, — An NCI-COG press release about the launch of a nationwide clinical trial that aims to match targeted treatments to pediatric cancers with specific genetic mutations.

December 28, — The drug selumetinib shrunk neural tumors in children with plexiform neurofibromas. September 16, — The new rule expands the legal requirements for submitting registration and results information for clinical trials involving U.

Home Subjects clinical trials Jef Akst Oct 12, Researchers say they hope to launch a clinical trial to test bumetanide, a diuretic approved in , but how it might improve neural functioning is unclear.

Merck reports that its antiviral molnupiravir was effective against early stages of COVID in high-risk patients in a Phase 3 clinical trial. Amanda Heidt Aug 12, The FDA pauses the research program on a lentivirus-based treatment for a rare neurological condition after a patient developed a bone marrow disorder that could presage leukemia.

Shawna Williams Jun 1, With multiple microbiota therapeutics in the pipeline for recurrent Clostridium difficile infection, clinicians foresee a shift in treatment options for the condition. Roni Dengler, PhD Jul 20, An unfolded protein found in human milk shows promise in early clinical trials to treat bladder cancer. Alejandra Manjarrez May 24, After receiving an intraocular injection of the gene for a light-sensitive protein, a year-old man diagnosed with the neurodegenerative eye disease retinitis pigmentosa was able to locate objects on a table using engineered goggles.

They predicted direct-to-patient drug shipments, supply chain digitization, payviders, and AI with wearables and other clinical data, and more. The multiple myeloma patient similarity network MM-PSN is one of the latest computational modeling tools being used here to translate clinical data into better treatment decision-making in the clinic, and the first to apply multiomics to the stratification of patients with the blood cancer.

We also explored practical ideas for increasing clinical trial diversity and reported on a new initiative for better data sharing and standardization in the realm of rare diseases. Still, the adoption of DCTs requires a fundamental shift in infrastructure to maintain compliance. This not only includes a shift to the cloud for virtual collaboration between stakeholders and data sharing, but also the elements of infrastructure that cannot be virtualized, such as the cold chain.